Long-term treatment with botulinum toxin A (BoNT-A) stabilizes or improves motor function in children with cerebral palsy (CP) who have mild walking difficulties, according to a study from Australia. The work also found that comorbidities (simultaneous medical conditions) were less frequent among children whose gross motor skills improved…
Chronic pain is an ongoing challenge for many children living with dyskinetic subtypes of cerebral palsy (CP), according to a new study that emphasizes the need to listen to the voices of those affected, both for caregivers and in the context of CP pain research. The study, “…
A clear hand preference in the first year or two of life, and delayed motor milestones are commonly cited as early signs of cerebral palsy (CP), a review study reported. But care providers need more to act on suspicions of CP promptly, getting a young child into rehabilitation and treatments…
Introducing an adaptive seating system into the wheelchairs of children with non-ambulatory cerebral palsy (CP) may be associated with short-term gains in body function, social activities, and participation, and with positive effects in other aspects of the child’s environment, according to a recent study. The study, “…
BcL-2, a protein that regulates cell death, has been identified as a potential marker for intrauterine growth restriction, an obstetric condition that can lead to cerebral palsy in affected children, a study suggests. Higher levels of this protein were found in maternal and umbilical cord blood in late preterm…
Lexus and and Axalta are different companies with a common goal: producing “toy” vehicles that help children with cognitive or physical challenges be more mobility while having fun. Lexus, the automaker, partnered with the Cerebral Palsy Foundation (CPF) to create a unique ride-on car for a young cerebral…
A single intramuscular injection of botulinum toxin A — more commonly known as botox — can significantly reduce upper limb spasticity and improve functional outcomes in children with cerebral palsy, a study finds. The study, “Effect of botulinum toxin type-A in spasticity and functional outcome of…
In recognition of Rare Disease Day Feb. 29, BioNews Services launched a social media campaign last month asking patients to describe what makes them rare. Running Feb. 7–29, the #WhatMakesMeRare campaign was aimed at uplifting people with rare diseases by encouraging them to share their stories and perspectives. The…
A multidisciplinary approach consisting of different treatment strategies for dyskinetic cerebral palsy (DCP) due to bilirubin encephalopathy — a condition in which damage arises due to very high levels of bilirubin, a substance produced by the breakdown of red blood cells — is necessary to improve daily life for…
Nearly three-quarters of adults with cerebral palsy experience pain as a symptom, a meta-analysis suggests. “Pain in adults with cerebral palsy: a systematic review and meta-analysis of individual participant data,” the analysis was published in the Annals of Physical and Rehabilitation Medicine. Many adults with cerebral palsy…